semaglutide immunoassay fda cleared detection assay immunoassay LupinInNews: Lupin announced that it has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Applications for Liraglutide Injection Single-Patient-Use fda cleared immunoassay semaglutide detection

Akkermansia Muciniphila AKK11, Bifidobacterium Infantis BI02

Da SilvaLEde OliveiraMPda SilvaMRAbelJSTartariGde Aguiar da CostaMet al

Main Research Findings 1) Semaglutide successfully lowered levels of HbA1c in a dose dependent manner and resulted in a significant loss in body weight without any episodes of excessive hypoglycemia

They can significantly reduce LDL cholesterol

In the context of obesity, our last Substack post was focused mainly on the central (brain) effects of GLP1R agonists in being able to control appetite

Despite its efficacy in glycemic control and weight reduction, several factors prompt patients to consider discontinuation